Matomo

Submit A Case
Home - Network - Working Groups - Rare Disease Working Groups - Vascular Ehlers-Danlos syndr. (MSA-WG) - Clinical Decision Support Tools - Clinical Expert Consensus Statements Written
Vascular Ehlers-Danlos syndr. (MSA-WG)
Introduction Diseases covered
Experts & Centers
Experts Centers
Clinical Decision Support Tools
Patient Pathways Do’s and Don’ts Clinical Practice Guidelines (CPGs) adopted Clinical Expert Consensus Statements Written Clinical Outcome Measures
Registry
Research
Clinical Trials/Observational Studies Research Publications
Training and Education
E-Learning Pills of Knowledge (PoK) Webinars

Clinical Expert Consensus Statements Written

The Medium Sized Arteries Working Group (MSA-WG) have developed consensus statements drawing from the latest research and clinical data to provide evidence-based recommendations for the diagnosis, treatment and management of these diseases.

The MSA WG is currently working on the production of consensus statement documents on various topics such as in vitro fertilization (IVF) and pre-implantation genetic diagnosis (PGD) in vEDS.

Results (2)
Consensus Statement on COVID-19 vaccination for patients with vascular Ehlers-Danlos syndrome
January 18 2021

The VASCERN Medium Sized Arteries Working Group experts provided an opinion statement on vaccination for patients with vascular Ehlers-Danlos Syndrome (vEDS).

Consensus statement on COVID-19 & vascular Ehlers-Danlos Syndrome
March 03 2020

With the global spread of the novel coronavirus SARS Cov-2, causing COVID 19, the VASCERN Medium Sized Arteries Working Group experts echoed some of the WHO guidelines regarding the virus specific to the vascular Ehlers-Danlos Syndrome (vEDS) community.

Skip to content